On November 9, 2020 Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, reported that the company reported that it will participate in the Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper) Annual Meeting online, November 11-14, including poster presentations on November 11th – 13th (Press release, Personalis, NOV 9, 2020, View Source [SID1234570542]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The company will showcase ImmunoID NeXT, the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample. ImmunoID NeXT can be used to investigate the key tumor and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.
Following is a list of abstracts that will be presented at the meeting.
Scientific Poster Presentations
Poster Number & Category
Title & Presenter
Day & Time
29
Biomarkers, Immune Monitoring, and Novel Technologies
Profiling Tumor Circulating Cell-Free DNA with an Enhanced Whole-Exome to Enable Sensitive Assessment of Somatic Mutations
Presenter: Simo V. Zhang, PhD
NOV 11 | 5:15 – 5:45 PM EST
and
NOV 13 | 4:40 – 5:10 PM EST
57
Biomarkers, Immune Monitoring, and Novel Technologies
Precision neoantigen discovery using novel algorithms and expanded HLA-ligandome datasets
Presenter: Dattatreya Mellacheruvu, PhD
NOV 11 | 5:15 – 5:45 PM EST
and
NOV 13 | 4:40 – 5:10 PM EST
67
Biomarkers, Immune Monitoring, and Novel Technologies
B-cell receptor heavy chain repertoire profiling using an augmented transcriptome
Presenter: Eric Levy, Ph.D.
NOV 11 | 5:15 – 5:45 PM EST
and
NOV 13 | 4:40 – 5:10 PM EST
73
Biomarkers, Immune Monitoring, and Novel Technologies
Orthogonally and functionally validated algorithm for detecting HLA loss of heterozygosity
Presenter: Rachel M. Pyke, PhD
NOV 11 | 5:15 – 5:45 PM EST
and
NOV 13 | 4:40 – 5:10 PM EST
Following are details of an industry-sponsored symposium which will be presented at the meeting.
Industry Sponsor Symposium
Presentation Category
Title & Presenter
Day & Time
Sponsored Symposia
Maximizing immunotherapy biomarker discovery with a multidimensional tumor immunogenomics platform
Presenter: Erin N. Newburn, PhD
NOV 12 | 12:30 – 12:50 PM EST
Personalis will also be exhibiting during the online conference. Representatives will be available to answer questions about the company’s cancer immunogenomics services.